Related Experiment Videos
The relationship between insulin-like growth factor-I, adiposity, and aging
K C Copeland1, R B Colletti, J T Devlin
1Department of Pediatrics, University of Vermont College of Medicine, Burlington 05405.
Metabolism: Clinical and Experimental
|June 1, 1990
Summary
Aging and increased body fat are linked to lower insulin-like growth factor-I (IGF-I) levels. This decline in IGF-I, an indicator of growth hormone (GH) secretion, was observed in both sexes but was more pronounced with higher body mass index in males.
Area of Science:
- Endocrinology
- Gerontology
- Human Physiology
Background:
- Aging is characterized by increased body fat and reduced growth hormone (GH) secretion.
- Insulin-like growth factor-I (IGF-I) serves as a key indicator of GH activity.
- Understanding the interplay between aging, body composition, and IGF-I is crucial for metabolic health.
Purpose of the Study:
- To investigate the relationship between plasma IGF-I levels and anthropometric measures of body fat in a diverse age group.
- To determine if age and body fat independently influence IGF-I concentrations.
- To explore potential sex-specific differences in these associations.
Main Methods:
- Assessed somatic and biochemical nutritional indices in 107 healthy adult subjects (ages 17-83).
- Measured plasma IGF-I levels.
- Utilized correlation and multiple regression analyses to examine relationships between IGF-I, age, and body fat indices (BMI, triceps skinfold, body weight).
Main Results:
- Plasma IGF-I showed a significant negative correlation with age in both males and females.
- In males, IGF-I negatively correlated with body mass index (BMI), triceps skinfold (TSF), and body weight, independent of age.
- These adiposity-IGF-I correlations were not significant in females.
Conclusions:
- Adiposity and aging are independently associated with decreased plasma IGF-I concentrations.
- The decline in IGF-I with aging occurs in both sexes, but its association with increased adiposity is primarily observed in males.
- Sex differences in gonadal steroids may interact with declining GH secretion to influence age-related obesity development in males.